Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease
NCT ID: NCT01854242
Last Updated: 2020-07-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2013-11-30
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184
Gene Expression in Inflammatory Bowel Disease
NCT01171872
Collection of Specimens for Study of Inflammatory Bowel Disease
NCT00086554
Genetic Studies of Inflammatory Bowel Disease
NCT00340444
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
NCT02054533
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
As a participant in this research study, a blood sample will be collected during your admission to the University of Florida. This will not affect the length of stay of your scheduled visit. There will be no scheduled clinic follow-up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glycogen Storage Disease type Ia patients
The participants will have one blood draw for this study. The test will be performed on the blood.
Glycogen Storage Disease type Ia patients
The participants will have one blood draw for this study. The test will be performed on the blood.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glycogen Storage Disease type Ia patients
The participants will have one blood draw for this study. The test will be performed on the blood.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prometheus Laboratories
INDUSTRY
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicole T Lawrence, MD
Role: PRINCIPAL_INVESTIGATOR
University of Florida
David A Weinstein, MD
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Florida and Shands
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COL13IBD01
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB201300312
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.